LBH589 and Gemcitabine in the Treatment of Solid Tumors

This study has been suspended.

( Suspended pending an amendment to the protocol for IV administration of LBH589 )

Study NCT00550199 Information provided by Sarah Cannon Research Institute

First Received: October 26, 2007 Last Updated: December 29, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been suspended.
Estimated Study Completion Date:	November 2009
Estimated Primary Completion Date:	November 2008 (Final data collection date for primary outcome measure)